| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $21.16B | +3.2% |
| R&D Expense | $556.0M | +13.0% |
| SG&A Expense | $2.51B | +1.6% |
| Operating Income | $1.19B | -9.5% |
| Pre-tax Income | $22.0M | -94.9% |
| Income Tax | $600.0M | -20.8% |
| Net Income | -$601.0M | -174.4% |
| EPS (Diluted) | -$0.61 | -125.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $5.96B | +5.4% |
| Inventory | $4.59B | +15.3% |
| Current Assets | $14.59B | -3.1% |
| Total Assets | $34.18B | -3.2% |
| Current Liabilities | $11.07B | +21.3% |
| Long-term Debt | $5.98B | -10.6% |
| Stockholders' Equity | $14.39B | -2.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.89B | -20.5% |
| Investing Cash Flow | -$1.56B | -237.8% |
| Financing Cash Flow | -$1.59B | +25.7% |